01:16a | Roche's Bispecific Antibody Shows Clinical Benefit in Aggressive Lymphoma Patients | MT |
05/26 | ZOOM VIDEO COMMUNICATIONS, INC. : An attempt to reconnect | |
05/26 | UK Agency Warns Patients About Cracks, Leaks in Roche's Insulin Devices | MT |
05/26 | Pfizer Receives US FDA Fast Track Designation for Ervogastat/Clesacostat Combination to.. | MT |
05/26 | Legend Biotech Receives Conditional European Commission Approval for Multiple Myeloma D.. | MT |
05/26 | ROCHE HOLDINGS AG : Deutsche Bank reaffirms its Neutral rating | MD |
05/26 | ROCHE HOLDINGS AG : Bernstein reaffirms its Buy rating | MD |
05/26 | UK Competition Watchdog Prepares For Supreme Court Order To Cover Pfizer, Flynn Pharma'.. | MT |
05/25 | Eli Lilly to Spend $2.1 Billion on Two New Manufacturing Facilities in US | MT |
05/25 | INSIDER SELL : Abbvie | MT |
05/25 | Eli Lilly and Company to Expand Manufacturing Sites in Indiana | MT |
05/25 | Lilly to Invest $2.1 Billion in New Manufacturing Sites in Indiana | DJ |
05/25 | Roche's Polivy Receives EU Approval for Lymphoma Treatment | MT |
05/25 | Roche develops test kits to detect monkeypox virus | RE |
05/25 | Roche Develops PCR Tests to Detect Monkeypox Virus | DJ |
05/25 | CORRECTION : Roche Develops PCR Tests for Monkeypox Virus Research | MT |
05/25 | Roche Develops PCR Tests for Monkeypox Virus Research | MT |
05/25 | Roche develops test kits to detect monkeypox virus | RE |
05/25 | European Commission Approves Roche's Polivy Combination for People with Previously Untr.. | CI |
05/25 | PFIZER INC : Goldman Sachs reiterates its Neutral rating | MD |
05/25 | Teva Pharmaceutical Settles Opioid Suit With West Virginia | DJ |
05/25 | Pfizer Launches Initiative to Sell Medicines, Vaccines to 45 Low-Income Countries on a .. | MT |
05/25 | Pfizer to Make Patented Treatments Available at Cost in Lower-Income Countries | MT |
05/25 | ROCHE HOLDING AG(SWX : RO) added to Swiss Performance Index (Price Return) | CI |
05/24 | TRANSCRIPT : Pfizer Inc. - Special Call | CI |
05/24 | TRANSCRIPT : Johnson & Johnson Presents at UBS Global Healthcare Conference, May-24-2022 1.. | CI |
05/24 | TRANSCRIPT : Eli Lilly and Company Presents at UBS Global Healthcare Conference, May-24-20.. | CI |
05/24 | Pfizer Inc. Presents ELEVATE Pivotal Findings Demonstrating Etrasimods Potentiall.. | CI |
05/24 | Pfizer Sees Positive Results in Etrasimod Trials | DJ |
05/24 | Eli Lilly and Company Announces Updates on Lilly's Pivotal Phase 3 Study | CI |
05/23 | Roche Secures Exclusive Licensing Deal For KaliVir's Novel Oncolytic Vaccinia Viruses | MT |
05/23 | Bayer's Xarelto Shows Long-Term Effect in Heart Disease Patients | MT |
05/23 | What you need to know about the coronavirus right now | RE |
05/23 | AbbVie Presents Positive Data from Phase 3 Study of Cariprazine (VRAYLAR®) for Adjuncti.. | CI |
05/23 | Pfizer, BioNTech Say Third Dose of COVID-19 Vaccine About 80% Effective in Children Age.. | MT |
05/23 | Pfizer, BioNTech Publish Data Supporting COVID-19 Vaccine Efficacy In Children Aged Six.. | MT |
05/23 | SVB Securities Initiates Eli Lilly and Co. at Outperform With $341 Price Target | MT |
05/23 | SVB Securities Initiates AbbVie at Underperform With $140 Price Target | MT |
05/23 | Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and.. | CI |
05/23 | ANALYST RECOMMANDATIONS : AbbVie, Amgen, Caterpillar, HP, Nike... | |
05/23 | AbbVie Says EMA Committee Backs Approval of Bowel Disease Drug Candidate | MT |
05/23 | AbbVie Inc. Announces CHMP Recommended European Commission Approval of Upadacitinib (RI.. | CI |
05/20 | Wall Street ends mixed after punishing week | RE |
05/20 | DOJ Objects to Cost of J&J Talc Unit Hiring Katyal For Appeal | DJ |
05/20 | Top Midday Gainers | MT |
05/20 | Rite Aid to Start Administering Pfizer's Booster Shot to Chidren Ages 5 to 11 | MT |
05/20 | Pfizer Enters Deal to Sell COVID-19 Drug Paxlovid to Switzerland | MT |
05/20 | Pfizer's Xeljanz Recommended By European Medicines Agency Committee to Treat Ankylosing.. | MT |
05/20 | Switzerland Secures Order for Pfizer's Antiviral COVID-19 Drug Paxlovid | MT |
05/20 | Immix Biopharma Says Cancer Drug IMX-110 Showed Higher Survival Rate Versus Johnson & J.. | MT |